Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia
暂无分享,去创建一个
Sylvie Belleville | John Kirk | Howard Chertkow | Howard Bergman | Morris Freedman | Yves Joanette | Christian Bocti | Fadi Massoud | Ziad Nasreddine | Valérie Drolet
[1] Janice E Graham,et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population , 1997, The Lancet.
[2] D. Zaitchik,et al. Predicting conversion to Alzheimer disease using standardized clinical information. , 2000, Archives of neurology.
[3] G. Adler,et al. Mild Cognitive Impairment in Old-Age Depression Is Associated with Increased EEG Slow-Wave Power , 1999, Neuropsychobiology.
[4] Hiroko H Dodge,et al. Exercise Level and Cognitive Decline: The MoVIES Project , 2004, Alzheimer disease and associated disorders.
[5] H. Tuokko,et al. Five-year follow-up of cognitive impairment with no dementia. , 2003, Archives of neurology.
[6] L. Candelise,et al. Galantamine for Alzheimer’s Disease and Mild Cognitive Impairment , 2007, Neuroepidemiology.
[7] Yvette I. Sheline,et al. Potential antecedent marker of Alzheimer disease , 2006 .
[8] P. Knipschild,et al. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial. , 2003, Journal of clinical epidemiology.
[9] K. Ottenbacher,et al. The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis. , 2004, Archives of physical medicine and rehabilitation.
[10] H. Wiśniewski,et al. Alzheimer's disease and related disorders. , 1986, British medical bulletin.
[11] H. Buschke,et al. The effects of preclinical dementia on estimates of normal cognitive functioning in aging. , 1996, The journals of gerontology. Series B, Psychological sciences and social sciences.
[12] K. Blennow,et al. Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment , 1999, Neuroscience Letters.
[13] J. Schneider,et al. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions , 2005, Neurology.
[14] C. Good,et al. Diet and serum potassium in patients on ACE inhibitors. , 1995, JAMA.
[15] I. Deary,et al. The Effects of Antihypertensive Treatment on Cognitive Function: Results from the HOPE Study , 1996, Journal of the American Geriatrics Society.
[16] Sylvie Belleville,et al. Improvement of Episodic Memory in Persons with Mild Cognitive Impairment and Healthy Older Adults: Evidence from a Cognitive Intervention Program , 2006, Dementia and Geriatric Cognitive Disorders.
[17] P. Scheltens,et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.
[18] B L Holman,et al. Preclinical prediction of Alzheimer's disease using SPECT , 1998, Neurology.
[19] Y. Joanette,et al. Mild cognitive impairment and cognitive impairment, no dementia: Part A, concept and diagnosis , 2007, Alzheimer's & Dementia.
[20] G. Schellenberg,et al. Impaired olfaction as a marker for cognitive decline: Interaction with apolipoprotein E 4 status , 1999 .
[21] R. Collins,et al. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions , 2004, The Lancet.
[22] B. Winblad,et al. Influence of social network on occurrence of dementia: a community-based longitudinal study , 2000, The Lancet.
[23] Robert D. Harris,et al. Vascular , 1993 .
[24] E. Tangalos,et al. CME Practice parameter: , 2022 .
[25] E B Larson,et al. Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status. , 1999, Neurology.
[26] Mark S. Cohen,et al. Patterns of brain activation in people at risk for Alzheimer's disease. , 2000, The New England journal of medicine.
[27] Ayanna K. Thomas,et al. Theoretical Perspectives on Cognitive Aging , 2019, Handbook of Medical Neuropsychology.
[28] E G Tangalos,et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease , 2000, Neurology.
[29] J. Jolles,et al. Distinction Between Preclinical Alzheimer's Disease and Depression , 2000, Journal of the American Geriatrics Society.
[30] A. Ott. Risk of dementia: The Rotterdam Study , 1997 .
[31] G. Alexopoulos. Heterogeneity and comorbidity in dementia‐depression syndromes , 1991 .
[32] A. Drzezga,et al. Primary Degenerative Mild Cognitive Impairment: Study Population, Clinical, Brain Imaging and Biochemical Findings , 2001, Dementia and Geriatric Cognitive Disorders.
[33] Timothy Kwok,et al. Cognitive intervention for community‐dwelling older persons with memory problems: telemedicine versus face‐to‐face treatment , 2005, International journal of geriatric psychiatry.
[34] P. Macfarlane,et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial , 2002, The Lancet.
[35] L. Goossens,et al. Improving memory performance in the aged through mnemonic training: a meta-analytic study. , 1992, Psychology and aging.
[36] W. Greenough,et al. Environmental influences on cognitive and brain plasticity during aging. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.
[37] J. Schneider,et al. Neuropathology of older persons without cognitive impairment from two community-based studies , 2006, Neurology.
[38] W. Snow,et al. The prediction of Alzheimer disease. The role of patient and informant perceptions of cognitive deficits. , 1996, Archives of neurology.
[39] George W Rebok,et al. Effects of cognitive training interventions with older adults: a randomized controlled trial. , 2002, JAMA.
[40] M. Bobinski,et al. Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET) , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[41] J. Schneider,et al. Individual differences in rates of change in cognitive abilities of older persons. , 2002, Psychology and aging.
[42] H. Chertkow,et al. Evaluation of heme oxygenase-1 as a systemic biological marker of sporadic AD , 2000, Neurology.
[43] H. Tuokko,et al. Cognitive Impairment with No Dementia (CIND): Longitudinal Studies, the Findings, and the Issues , 2000, The Clinical neuropsychologist.
[44] B. Boeve,et al. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy , 2001, Movement disorders : official journal of the Movement Disorder Society.
[45] A. Smith,et al. Use of structural imaging to study the progression of Alzheimer's disease. , 1996, British medical bulletin.
[46] D. Schaid,et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. , 1995, JAMA.
[47] Alessandro Padovani,et al. The Predementia Diagnosis of Alzheimer Disease , 2004, Alzheimer disease and associated disorders.
[48] E. Barrett-Connor,et al. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women , 2004, Neurology.
[49] K. Meguro,et al. Therapeutic Psychosocial Intervention for Elderly Subjects With Very Mild Alzheimer Disease in a Community: The Tajiri Project , 2002, Alzheimer disease and associated disorders.
[50] C. Junqué,et al. Neuropsychological and Genetic Differences Between Age‐Associated Memory Impairment and Mild Cognitive Impairment Entities , 2001, Journal of the American Geriatrics Society.
[51] R. Petersen,et al. Mild cognitive impairment: transition between aging and Alzheimer's disease. , 2000, Neurologia.
[52] C. Kawas,et al. Plasma total cholesterol, LDL, HDL levels and the risk of Alzheimer disease The Baltimore Longitudinal Study of Aging , 2002 .
[53] C. Jonker,et al. Are memory complaints predictive for dementia? A review of clinical and population‐based studies , 2000, International journal of geriatric psychiatry.
[54] H. Kavirajan,et al. Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease , 2005, Neurology.
[55] D. A. Bennett,et al. Natural history of mild cognitive impairment in older persons , 2002, Neurology.
[56] Howard Chertkow,et al. Olfaction in patients with mild cognitive impairment and Alzheimer's disease , 2008, Neurobiology of Aging.
[57] J. Schneider,et al. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. , 2002, JAMA.
[58] T. Fritsch,et al. The relationships between television viewing in midlife and the development of Alzheimer’s disease in a case-control study , 2005, Brain and Cognition.
[59] Nick C Fox,et al. Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study , 2007, The Lancet Neurology.
[60] Robert B Wallace,et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. , 2003, JAMA.
[61] The incidence of dementia in Canada. The Canadian Study of Health and Aging Working Group. , 2000, Neurology.
[62] J. Tuomilehto,et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial , 1998, The Lancet.
[63] J. Cummings,et al. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.
[64] R. D'Agostino,et al. Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study , 2003, International Journal of Obesity.
[65] Andrew Kertesz,et al. Diagnosis and treatment of dementia: 2. Diagnosis , 2008, Canadian Medical Association Journal.
[66] J. Touchon,et al. A Typology of Sub-Clinical Senescent Cognitive Disorder , 1996, British Journal of Psychiatry.
[67] Kenneth Rockwood,et al. Variations in case definition affect prevalence but not outcomes of mild cognitive impairment , 2003, Neurology.
[68] L. Thal,et al. A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment , 2005, Neuropsychopharmacology.
[69] V. Hachinski. Preventable senility: a call for action against the vascular dementias , 1992, The Lancet.
[70] Neil Chapman,et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. , 2003, Archives of internal medicine.
[71] J. Touchon,et al. Disability and mild cognitive impairment: a longitudinal population‐based study , 2001, International journal of geriatric psychiatry.
[72] S. Salloway,et al. Efficacy of donepezil in mild cognitive impairment , 2004, Neurology.
[73] S. Thibodeau,et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.
[74] M. Samuel,et al. Efficacy and Safety of OK-432 Sclerotherapy for Giant Cystic Hygroma in a Newborn , 2000, Fetal Diagnosis and Therapy.
[75] D. Hogan,et al. Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging. , 1995, Archives of neurology.
[76] M. Freedman,et al. Mild cognitive impairment and cognitive impairment, no dementia: Part B, therapy , 2007, Alzheimer's & Dementia.
[77] G. Kemmler,et al. Long-term improvements in cognitive performance through computer-assisted cognitive training: A pilot study in a residential home for older people , 2003, Aging & mental health.
[78] H. Chertkow. Diagnosis and treatment of dementia: Introduction. Introducing a series based on the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia , 2007, Canadian Medical Association Journal.
[79] S. Gauthier,et al. Mild cognitive impairment is not a clinical entity and should not be treated. , 2005, Archives of neurology.
[80] R. Petersen,et al. Aging, mild cognitive impairment, and Alzheimer's disease. , 2000, Neurologic clinics.
[81] C. Patterson,et al. Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease , 2008, Canadian Medical Association Journal.
[82] H Bergman,et al. Lack of Prognostic Significance of SPECT Abnormalities in Non-demented Elderly Subjects with Memory Loss , 1999, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[83] C. Gottfries,et al. Identification of Cognitive Impairment in the Elderly: Homocysteine Is an Early Marker , 1998, Dementia and Geriatric Cognitive Disorders.
[84] R. Petersen,et al. Mild cognitive impairment , 2006, The Lancet.
[85] J. Price,et al. Mild cognitive impairment represents early-stage Alzheimer disease. , 2001, Archives of neurology.
[86] D. Blacker. Mild cognitive impairment--no benefit from vitamin E, little from donepezil. , 2005, The New England journal of medicine.
[87] Hilkka Soininen,et al. Prevalence of mild cognitive impairment: A population-based study in elderly subjects , 2000, Neurobiology of Aging.
[88] D. Riemann,et al. Cholinergic neurotransmission, REM sleep and depression. , 1994, Journal of psychosomatic research.
[89] D. Bliwise. Is sleep apnea a cause of reversible dementia in old age? , 1996, Journal of the American Geriatrics Society.
[90] P. Neu,et al. Comorbidity of mild cognitive disorder and depression – a neuropsychological analysis , 2000, European Archives of Psychiatry and Clinical Neuroscience.
[91] K. Marder,et al. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. , 2000, The American journal of psychiatry.
[92] J. Kessler,et al. DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia , 2004, International journal of geriatric psychiatry.
[93] N. Fox. Increased rates of atrophy in early and preclinical AD: Studies with registration of serial MRI , 2000, Neurobiology of Aging.
[94] C. Jack,et al. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease , 1998, Neurology.
[95] Agneta Nordberg,et al. PET imaging of amyloid in Alzheimer's disease , 2004, The Lancet Neurology.
[96] J. Jolles,et al. Ten-year risk of dementia in subjects with mild cognitive impairment , 2006, Neurology.
[97] T. Grabowski. Preclinical Alzheimer Disease: Neuropsychological Test Performance 1.5 to 8 Years Prior to Onset , 2006 .
[98] A P Marsh,et al. Memory enhancement training for older adults with mild cognitive impairment: A preliminary study , 2002, Aging & mental health.
[99] A. Newman,et al. The metabolic syndrome, inflammation, and risk of cognitive decline. , 2004, JAMA.
[100] J. Lindsay,et al. Physical activity and risk of cognitive impairment and dementia in elderly persons. , 2001, Archives of neurology.
[101] A R Jadad,et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.
[102] H. Feldman,et al. The Consortium to Investigate Vascular Impairment of Cognition: Methods and First Findings , 2003, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[103] A. Mitchell,et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. , 2002, JAMA.
[104] D. Bennett. Mild cognitive impairment. , 2004, Clinics in geriatric medicine.
[105] Yaakov Stern,et al. Questionable Dementia: Clinical Course and Predictors of Outcome , 1997, Journal of the American Geriatrics Society.
[106] A. Levy,et al. A Canadian Cohort Study of Cognitive Impairment and Related Dementias (ACCORD): Study Methods and Baseline Results , 2003, Neuroepidemiology.
[107] D. Bennett. Update on mild cognitive impairment , 2003, Current neurology and neuroscience reports.
[108] M. Albert,et al. Preclinical prediction of AD using neuropsychological tests , 2001, Journal of the International Neuropsychological Society.
[109] M. Albert,et al. Amnestic MCI or prodromal Alzheimer's disease? , 2004, The Lancet Neurology.
[110] V. Hachinski. Vascular dementia: a radical redefinition. , 1994, Dementia.
[111] D. Bennett,et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. , 2005, The New England journal of medicine.
[112] E. Tangalos,et al. Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .
[113] G. Alexopoulos,et al. The course of geriatric depression with "reversible dementia": a controlled study. , 1993, The American journal of psychiatry.
[114] C. Jack,et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD , 2000, Neurology.
[115] K. Ball,et al. Long-term effects of cognitive training on everyday functional outcomes in older adults. , 2006, JAMA.